Home  
  Glamour
Shots
 
  FAQ  
  Contacts  
  Press
Kit
 
  Authorized Bio  
  Trailer  
  Flash
Trailer
 
  Screenings  
  Downloads  
  Newsletter  
  Official PayPal SealOfficial PayPal Seal  

Announced today enrollment of the first European patients in a Pilot Clinical Trial.

‘We are thrilled to be the first in European countries to bring this new device to patients. This technology gets the potential to improve the quality of life and possibly the outcomes of these suffering from Heart Failing and Central Rest Apnea,’ stated Prof. Ponikowski. ‘We are very pleased to accomplish that essential milestone for Cardiac Concepts. We anticipate including other centers inside our pilot study and providing doctors with new choices to treat Central Sleep Apnea in Center Failure sufferers,’ stated Bonnie Labosky, CEO of Cardiac Ideas, Inc.These details could help doctors offer targeted therapy particular to a patient’s cancers, they note. Recently, detection of cancer-particular mutations by genome sequencing offers attracted attention in an effort to help select appropriate therapy selection, Professor Chayama said. The researchers could actually recognize 25 common mutations in samples of cell-free DNA, which include DNA from both normal tumor and cells cells, and DNA from tumors themselves. Furthermore, 83 percent of mutations recognized in the tumor cells could possibly be detected in the cell-free DNA.

  Member Area  
  LLX Internet Services  
  Cornerstone 28  
  The Valet  
  Underground Railroad  
  Event Gallery  
  Sponsors  
  Endorsements  
  Moon in Leo Prod.  
  Diamond And Sphinx  
  Chris Cory  
  Site Update Log